mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.2 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.044 |
0.2 |
mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
0.045 |
0.2 |
mRNA |
CIL41 |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.2 |
mRNA |
BRD-K33514849 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
0.2 |
mRNA |
fingolimod |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.2 |
mRNA |
TGX221 |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.2 |
mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.2 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.044 |
0.2 |
mRNA |
Imatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.2 |